User profiles for Benjamin Seeliger
Benjamin SeeligerMedical Doctor, Hannover Medical School Verified email at mh-hannover.de Cited by 1589 |
[HTML][HTML] Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
…, C Feuerborn, P Maier, S Schulz, B Al, B Seeliger… - Nature, 2022 - nature.com
Anorexia and fasting are host adaptations to acute infection, and induce a metabolic switch
towards ketogenesis and the production of ketone bodies, including β-hydroxybutyrate (BHB) …
towards ketogenesis and the production of ketone bodies, including β-hydroxybutyrate (BHB) …
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
A Garg, B Seeliger, AA Derda, K Xiao… - European journal of …, 2021 - Wiley Online Library
Aims Coronavirus disease 2019 (COVID‐19) is a still growing pandemic, causing many
deaths and socio‐economic damage. Elevated expression of the severe acute respiratory …
deaths and socio‐economic damage. Elevated expression of the severe acute respiratory …
Between inflammation and thrombosis: endothelial cells in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current
coronavirus disease (COVID-19) pandemic [1]. Over recent months, a plethora of novel research …
coronavirus disease (COVID-19) pandemic [1]. Over recent months, a plethora of novel research …
[HTML][HTML] Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
[HTML][HTML] Injury to the endothelial glycocalyx in critically ill patients with COVID-19
K Stahl, PA Gronski, Y Kiyan, B Seeliger… - American journal of …, 2020 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the so-called
coronavirus disease (COVID-19), which is characterized by a broad spectrum of clinical …
coronavirus disease (COVID-19), which is characterized by a broad spectrum of clinical …
[HTML][HTML] Anti-IL-5 therapy in patients with severe eosinophilic asthma–clinical efficacy and possible criteria for treatment response
N Drick, B Seeliger, T Welte, J Fuge… - BMC pulmonary medicine, 2018 - Springer
Background Interleukin-5 (IL-5) antibodies represent a promising therapeutic option for patients
with severe eosinophilic asthma. To date, no official treatment response criteria exist. In …
with severe eosinophilic asthma. To date, no official treatment response criteria exist. In …
Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
Objectives. Advances in diagnostic techniques have led to better distinction between types of
vasculitis, potentially affecting the utility of the 1990 ACR classification criteria for vasculitis. …
vasculitis, potentially affecting the utility of the 1990 ACR classification criteria for vasculitis. …
[HTML][HTML] Neuro-Sjögren: peripheral neuropathy with limb weakness in Sjögren's syndrome
T Seeliger, NK Prenzler, S Gingele, B Seeliger… - Frontiers in …, 2019 - frontiersin.org
Objective: Sjögren's syndrome is a heterogeneous inflammatory disorder frequently involving
peripheral nerves with a wide spectrum of sensory modalities and distribution patterns. …
peripheral nerves with a wide spectrum of sensory modalities and distribution patterns. …
[HTML][HTML] The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling
…, PD Lee, MM Hoeper, T Welte, B Seeliger… - …, 2022 - thelancet.com
Background COVID-19 is characterized by a heterogeneous clinical presentation, ranging
from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe …
from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe …